Company Filing History:
Years Active: 1997-1998
Title: Innovations by John Gustofson in RNA Research
Introduction
John Gustofson is a notable inventor based in Boulder, CO (US), recognized for his contributions to the field of RNA research. He holds 2 patents that focus on innovative methods to address arthritic conditions through enzymatic RNA molecules.
Latest Patents
Gustofson's latest patents include a "Method of reducing stromelysin RNA via ribozymes," which describes an enzymatic RNA molecule that cleaves mRNA associated with the development or maintenance of an arthritic condition. Another significant patent is "Stromelysin targeted ribozymes," which also focuses on an enzymatic RNA molecule aimed at the same health issue.
Career Highlights
John Gustofson is affiliated with Ribozyme Pharmaceuticals, Incorporated, where he applies his expertise in RNA technology to develop therapeutic solutions. His work has been instrumental in advancing the understanding of RNA's role in disease management.
Collaborations
Gustofson has collaborated with notable colleagues, including Kenneth G Draper and Pamela Pavco, contributing to a dynamic research environment that fosters innovation.
Conclusion
John Gustofson's work in RNA research exemplifies the intersection of science and innovation, particularly in addressing health challenges related to arthritis. His patents reflect a commitment to advancing medical science through inventive solutions.